These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19936977)

  • 1. GSK3B and schizophrenia: a case not closed.
    Sand PG; Domani M; Smesny S
    Psychopharmacology (Berl); 2010 Feb; 208(2):333-4; author reply 335-6. PubMed ID: 19936977
    [No Abstract]   [Full Text] [Related]  

  • 2. Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response.
    Souza RP; Romano-Silva MA; Lieberman JA; Meltzer HY; Wong AH; Kennedy JL
    Psychopharmacology (Berl); 2008 Oct; 200(2):177-86. PubMed ID: 18500637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of glycogen synthase kinase-3β in the pathogenesis of mental disorders].
    Ivanova SA; Losenkov IS; Bokhan NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(6):93-100. PubMed ID: 25075421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association of GSK3beta gene (GSK3B) with Japanese schizophrenia.
    Ikeda M; Iwata N; Suzuki T; Kitajima T; Yamanouchi Y; Kinoshita Y; Ozaki N
    Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):90-2. PubMed ID: 15719395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population.
    Chen J; Wang M; Waheed Khan RA; He K; Wang Q; Li Z; Shen J; Song Z; Li W; Wen Z; Jiang Y; Xu Y; Shi Y; Ji W
    J Affect Disord; 2015 Oct; 185():149-55. PubMed ID: 26186530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine.
    Tsai SJ; Hong CJ; Yu YW; Lin CH; Liu LL
    Schizophr Res; 2003 Dec; 65(1):27-32. PubMed ID: 14623371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.
    Tang H; Shen N; Jin H; Liu D; Miao X; Zhu LQ
    Mol Neurobiol; 2013 Dec; 48(3):404-11. PubMed ID: 23440732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.
    Masellis M; Basile VS; Ozdemir V; Meltzer HY; Macciardi FM; Kennedy JL
    Biol Psychiatry; 2000 Feb; 47(3):252-66. PubMed ID: 10682223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-β activity.
    Benedetti F; Poletti S; Radaelli D; Bernasconi A; Cavallaro R; Falini A; Lorenzi C; Pirovano A; Dallaspezia S; Locatelli C; Scotti G; Smeraldi E
    Genes Brain Behav; 2010 Jun; 9(4):365-71. PubMed ID: 20113358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects.
    Kohn Y; Ebstein RP; Heresco-Levy U; Shapira B; Nemanov L; Gritsenko I; Avnon M; Lerer B
    Eur Neuropsychopharmacol; 1997 Feb; 7(1):39-43. PubMed ID: 9088883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients.
    Hong CJ; Yu YW; Lin CH; Tsai SJ
    Neurosci Lett; 2003 Oct; 349(3):206-8. PubMed ID: 12951204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association analysis of polymorphism in the promoter region of the alpha2a-adrenoceptor gene with schizophrenia and clozapine response.
    Tsai SJ; Wang YC; Yu Younger WY; Lin CH; Yang KH; Hong CJ
    Schizophr Res; 2001 Apr; 49(1-2):53-8. PubMed ID: 11343863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of dopamine receptor D1 rs4532 polymorphism and susceptibility to antipsychotic treatment response.
    de Matos LP; Santana CV; Souza RP
    Psychiatry Res; 2015 Sep; 229(1-2):586-8. PubMed ID: 26213377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An association study of the neurotensin receptor gene with schizophrenia and clozapine response.
    Huezo-Diaz P; Arranz MJ; Munro J; Osborne S; Makoff A; Kerwin RW; Austin J; O'Donovan M
    Schizophr Res; 2004 Feb; 66(2-3):193-5. PubMed ID: 15061255
    [No Abstract]   [Full Text] [Related]  

  • 15. [The relationship between glycogen synthase kinase-3 beta (GSK3B) -50T/C -1727A/T polymorphisms and alcoholism].
    Yoshihara E; Aoki J; Kurihara K; Numajiri M; Iwahashi K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2011 Dec; 46(6):570-5. PubMed ID: 22413565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia.
    Ferrari M; Bolla E; Bortolaso P; Callegari C; Poloni N; Lecchini S; Vender S; Marino F; Cosentino M
    Psychiatry Res; 2012 Dec; 200(2-3):1014-7. PubMed ID: 22901441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.
    Zhao Z; Ksiezak-Reding H; Riggio S; Haroutunian V; Pasinetti GM
    Schizophr Res; 2006 May; 84(1):1-14. PubMed ID: 16581231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.
    Szczepankiewicz A; Skibinska M; Hauser J; Slopien A; Leszczynska-Rodziewicz A; Kapelski P; Dmitrzak-Weglarz M; Czerski PM; Rybakowski JK
    Neuropsychobiology; 2006; 53(1):51-6. PubMed ID: 16397405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression.
    Ronai Z; Kovacs-Nagy R; Szantai E; Elek Z; Sasvari-Szekely M; Faludi G; Benkovits J; Rethelyi JM; Szekely A
    Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):217-22. PubMed ID: 24677591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action.
    Freyberg Z; Ferrando SJ; Javitch JA
    Am J Psychiatry; 2010 Apr; 167(4):388-96. PubMed ID: 19917593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.